201 related articles for article (PubMed ID: 29192329)
1. Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients.
Ryan Wolf J; Heckler CE; Guido JJ; Peoples AR; Gewandter JS; Ling M; Vinciguerra VP; Anderson T; Evans L; Wade J; Pentland AP; Morrow GR
Support Care Cancer; 2018 May; 26(5):1543-1552. PubMed ID: 29192329
[TBL] [Abstract][Full Text] [Related]
2. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients.
Ryan JL; Heckler CE; Ling M; Katz A; Williams JP; Pentland AP; Morrow GR
Radiat Res; 2013 Jul; 180(1):34-43. PubMed ID: 23745991
[TBL] [Abstract][Full Text] [Related]
3. Effect of Nano-Curcumin on Radiotherapy-Induced Skin Reaction in Breast Cancer Patients: A Randomized, Triple-Blind, Placebo-Controlled Trial.
Talakesh T; Tabatabaee N; Atoof F; Aliasgharzadeh A; Sarvizade M; Farhood B; Najafi M
Curr Radiopharm; 2022; 15(4):332-340. PubMed ID: 35747962
[TBL] [Abstract][Full Text] [Related]
4. Utility of topical agents for radiation dermatitis and pain: a randomized clinical trial.
Ryan Wolf J; Gewandter JS; Bautista J; Heckler CE; Strasser J; Dyk P; Anderson T; Gross H; Speer T; Dolohanty L; Bylund K; Pentland AP; Morrow GR
Support Care Cancer; 2020 Jul; 28(7):3303-3311. PubMed ID: 31758326
[TBL] [Abstract][Full Text] [Related]
5. Impact of Curcumin Supplementation on Radiation Dermatitis Severity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Mirzaei Dahka S; Afsharfar M; Tajaddod S; Sohouli MH; Shekari S; Bakhshi Nafouti F; Alizadeh A; Shafahi Kachaei H; Abbasi K; Khalatbari Mohseni G; Alami F; Gholamalizadeh M; Doaei S
Asian Pac J Cancer Prev; 2023 Mar; 24(3):783-789. PubMed ID: 36974529
[TBL] [Abstract][Full Text] [Related]
6. Randomized Double-blind Placebo-controlled Trial of Celecoxib for the Prevention of Skin Toxicity in Patients Receiving Radiation Therapy for Breast Cancer.
Ghasemi A; Danesh B; Yazdani-Charati J; Hosseinimehr SJ
Antiinflamm Antiallergy Agents Med Chem; 2018; 17(1):57-67. PubMed ID: 29651970
[TBL] [Abstract][Full Text] [Related]
7. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
Ulff E; Maroti M; Serup J; Falkmer U
Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
[TBL] [Abstract][Full Text] [Related]
8. Double-Blind, Placebo-Controlled Pilot Study of Processed Ultra Emu Oil Versus Placebo in the Prevention of Radiation Dermatitis.
Rollmann DC; Novotny PJ; Petersen IA; Garces YI; Bauer HJ; Yan ES; Wahner-Roedler D; Vincent A; Sloan JA; Issa Laack NN
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):650-8. PubMed ID: 25936812
[TBL] [Abstract][Full Text] [Related]
9. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
Ho AY; Olm-Shipman M; Zhang Z; Siu CT; Wilgucki M; Phung A; Arnold BB; Porinchak M; Lacouture M; McCormick B; Powell SN; Gelblum DY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):325-333. PubMed ID: 29726361
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic treatment with a potent corticosteroid cream ameliorates radiodermatitis, independent of radiation schedule: A randomized double blinded study.
Ulff E; Maroti M; Serup J; Nilsson M; Falkmer U
Radiother Oncol; 2017 Jan; 122(1):50-53. PubMed ID: 27913066
[TBL] [Abstract][Full Text] [Related]
11. Effect of melatonin cream on acute radiation dermatitis in patients with primary breast cancer: A double-blind, randomized, placebo-controlled trial.
Zetner D; Kamby C; Christophersen C; Gülen S; Paulsen CB; Piga E; Hoffmeyer B; Mahmood F; Rosenberg J
J Pineal Res; 2023 Aug; 75(1):e12873. PubMed ID: 37055944
[TBL] [Abstract][Full Text] [Related]
12. Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial.
Nabi-Meybodi M; Sahebnasagh A; Hakimi Z; Shabani M; Shakeri AA; Saghafi F
BMC Cancer; 2022 Oct; 22(1):1079. PubMed ID: 36266613
[TBL] [Abstract][Full Text] [Related]
13. Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial.
Ghasemi A; Ghashghai Z; Akbari J; Yazdani-Charati J; Salehifar E; Hosseinimehr SJ
Eur J Clin Pharmacol; 2019 Feb; 75(2):171-178. PubMed ID: 30291370
[TBL] [Abstract][Full Text] [Related]
14. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
[TBL] [Abstract][Full Text] [Related]
15. Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial.
Rafati M; Ghasemi A; Saeedi M; Habibi E; Salehifar E; Mosazadeh M; Maham M
Complement Ther Med; 2019 Dec; 47():102205. PubMed ID: 31780017
[TBL] [Abstract][Full Text] [Related]
16. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
[TBL] [Abstract][Full Text] [Related]
17. Prospective Study of Breast Radiation Dermatitis.
Drost L; Li N; Vesprini D; Sangha A; Lee J; Leung E; Rakovitch E; Yee C; Chow E; Ruschin M
Clin Breast Cancer; 2018 Oct; 18(5):e789-e795. PubMed ID: 29622382
[TBL] [Abstract][Full Text] [Related]
18. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4.
Miller RC; Schwartz DJ; Sloan JA; Griffin PC; Deming RL; Anders JC; Stoffel TJ; Haselow RE; Schaefer PL; Bearden JD; Atherton PJ; Loprinzi CL; Martenson JA
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1460-6. PubMed ID: 20800381
[TBL] [Abstract][Full Text] [Related]
19. The Preventive Effects of Boron-Based Gel on Radiation Dermatitis in Patients Being Treated for Breast Cancer: A Phase III Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Sahin F; Pirouzpanah MB; Bijanpour H; Mohammadzadeh M; Eghdam Zamiri R; Ghasemi Jangjoo A; Nasiri B; Saboori H; Doğan A; Demirci S; Ayşan E; Çağrı Büke A; Naseri AR; Shakouri SK; Aghamohammadi D; Alizade-Harakiyan M; Seyed Nejad F
Oncol Res Treat; 2022; 45(4):197-204. PubMed ID: 34979503
[TBL] [Abstract][Full Text] [Related]
20. A novel, multi-active emollient for the prevention of acute radiation dermatitis in breast cancer patients: a randomized clinical trial.
Robijns J; Van Bever L; Hermans S; Claes M; Lodewijckx J; Lenaerts M; Tuts L; Vandaele E; Vinken E; Noé L; Verboven K; Maes A; Van de Velde AS; Bulens P; Bulens P; Van den Bergh L; Mebis J
Support Care Cancer; 2023 Oct; 31(12):625. PubMed ID: 37819539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]